USPTO serial 79221443
PROTA THERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 5771963Status 706Registered
- Filing date
- Status date
- Registration date
- Jun 11, 2019
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with PROTA THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mainak H. Mehta
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Active specific immunotherapy agents for the treatment of allergic and intolerance disorders; antigens for the prevention and treatment of allergic and intolerance disorders; probiotic bacterial formulations for medical use; probiotic bacterial preparations for medical use; pharmaceutical preparations for oral use, namely, oral immunotherapy preparations for prevention and treatment of allergic and intolerance conditions; medical preparations for modifying allergic and intolerance conditions, namely, conditions affecting the gastrointestinal tract, skin, airways and/or lungs; pharmaceutical preparations for the treatment of food allergies or intolerances, and other allergic and intolerance conditions, namely, of the gastrointestinal tract, skin, airways and/or lungs, all of the foregoing for oral administration only | ACTIVE | — |
| 044 | Treatment of allergies; medical services; medical treatment and advisory services; medical testing and analysis services for the diagnosis of allergic and intolerance disorders; medical diagnostic services, namely, for the diagnosis of allergic and intolerance disorders; provision of pharmaceutical information, namely, pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Prota Therapeutics Pty Ltd
- Other trademarks owned by Prota Therapeutics Pty Ltd
- Other trademarks owned by Prota Therapeutics Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named PROTA THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 11, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Apr 6, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 11, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 11, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 11, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 24, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 24, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 11, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 11, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 10, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 7, 2019 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| May 6, 2019 | APET | ASSIGNED TO PETITION STAFF | — |
| Apr 24, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 24, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 11, 2019 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 1, 2019 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Oct 29, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 2, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 2, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 29, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 12, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 12, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 12, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 29, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 29, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 23, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 22, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 5, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 23, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |